Brenntag Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Brenntag wird ein jährliches Gewinn- und Umsatzwachstum von 15.1% bzw. 1.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 14.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.8% betragen.
Wichtige Informationen
15.1%
Wachstumsrate der Gewinne
14.09%
EPS-Wachstumsrate
| Trade Distributors Gewinnwachstum | 13.0% |
| Wachstumsrate der Einnahmen | 1.9% |
| Zukünftige Eigenkapitalrendite | 12.81% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 14 Aug 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Analyseartikel • Aug 15
Brenntag SE Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Brenntag SE ( ETR:BNR ) shareholders are probably feeling a little disappointed, since its shares fell 4.2% to €61.38...
Narrative-Update • Aug 10
BNR: Pricing Normalization And Resilient Demand Are Expected To Support Re Rating
The analyst price target for Brenntag has moved from about €68 to roughly €70, as analysts weigh mixed rating changes and updated views on pricing risks, demand resilience and relative valuation, which are reflected in the revised fair value, discount rate, revenue growth, profit margin and future P/E assumptions. Analyst Commentary Recent broker updates on Brenntag point to a more balanced view, with several bullish analysts shifting from negative stances to neutral ones and lifting price targets into the €52 to €57 range.
Narrative-Update • Jun 22
BNR: Easing Pricing Tailwinds Will Pressure Margins And Limit Upside Potential
The analyst price target for Brenntag has been reduced by €10 to €57. Analysts are factoring in Brenntag's exposure to easing pricing tailwinds in certain regions, while also noting relatively resilient demand and a steadier pricing backdrop compared with some peers.Narrative-Update • Jun 06
BNR: Resilient Demand Expectations Will Still Leave Execution Risks In Focus
The analyst fair value estimate for Brenntag has increased from €42.00 to €44.00, reflecting higher price targets from analysts, including recent upgrades that cite more resilient second half demand and a smaller expected price roll off compared with peers. Analyst Commentary Recent research on Brenntag shows a mix of optimism and caution.
Narrative-Update • May 23
BNR: Resilient Demand And Higher Discount Rate Will Shape Fairly Balanced Outlook
The analyst price target for Brenntag has shifted from roughly €53.86 to about €56.43. Analysts cite more resilient second half demand, a smaller price roll off versus peers, and recent rating and target increases from several firms as key drivers of the change.Narrative-Update • May 01
BNR: Higher Discount Rate And Lower P E May Cap Share Price
Analysts have trimmed their Brenntag price target slightly from about €54.50 to roughly €53.86. This reflects updates to assumptions on discount rate, revenue growth, profit margin and future P/E following recent UBS and Deutsche Bank research.Narrative-Update • Apr 15
BNR: Dividend And Epoxy Expansion Are Expected To Support Re Rating
Analysts have nudged their price target for Brenntag slightly higher to about €68, citing updated assumptions for revenue growth, profit margins and a lower future P/E multiple following recent research, including an upgrade at a major bank. Analyst Commentary Recent research points to a more constructive tone around Brenntag, with bullish analysts aligning their models to the updated assumptions on revenue growth, profit margins and future P/E multiples that underpin the new price target around €68.Narrative-Update • Apr 01
BNR: Sector Headwinds And Execution Risks Will Sustain Earnings Pressure
Narrative Update The analyst price target for Brenntag has been adjusted to €50. Analysts cite updated 2026 sector views, a more cautious stance on chemical distribution and staffing peers, and revised assumptions for discount rate, revenue growth, profit margin, and future P/E.Narrative-Update • Mar 18
BNR: Distribution Execution And Staffing Risks Will Sustain Earnings Pressure
Analysts have reduced their Brenntag price target to €50 from €63, citing a more cautious stance on chemical distribution and staffing within the broader European business services group. Analyst Commentary Bearish analysts have shifted to a more cautious stance on Brenntag, pointing to risks around execution in chemical distribution and staffing within the broader European business services group.Narrative-Update • Mar 04
BNR: Expanded Epoxy Partnership Will Support A More Constructive Long Term View
Our Brenntag narrative has been updated to reflect a lower analyst price target of €50, down from €63, as analysts factor in more cautious assumptions on revenue growth, profit margins and sector conditions, even while using a slightly higher discount rate and a higher future P/E multiple. Analyst Commentary The latest rating and price target move to €50 comes as part of a broader 2026 reassessment of European business services and chemical distribution names.Narrative-Update • Feb 18
BNR: Chemical Distribution Concerns Will Sustain Earnings Pressure And Extended Multiple Compression
Analysts have cut their price target on Brenntag to €50 from €63, reflecting a more cautious view on chemical distribution as they update their 2026 outlook and favor other business services names instead. Analyst Commentary Bearish analysts have moved Brenntag to a less favorable rating and cut the price target to €50 from €63, signaling a stricter view on what they are willing to pay for the shares in the medium term.Narrative-Update • Feb 03
BNR: Chemical Distribution Execution Risk Will Pressure Earnings And Sustain Multiple Compression
Narrative update on Brenntag Analysts have trimmed their average price target for Brenntag to €50 from €63. This reflects a more cautious view on chemical distribution and related business services, while still keeping fair value assumptions broadly unchanged.Narrative-Update • Jan 20
BNR: Staffing And Chemical Distribution Risks Will Pressure Earnings And Sustain Multiple Compression
Narrative Update on Brenntag Brenntag's analyst price target has been cut to €50 from €63, with analysts citing a more cautious view on chemical distribution and staffing exposure within their 2026 outlook. Analyst Commentary Bearish analysts have shifted their stance on Brenntag, cutting the price target to €50 from €63 and moving the rating to Underweight.Narrative-Update • Jan 06
BNR: Weaker Chemical Demand Will Pressure Earnings And Sustain Multiple Compression
Analysts have trimmed their average price targets on Brenntag to a range around €45 to €50, reflecting more cautious views on chemical distribution volumes and the company's growth profile. Analyst Commentary Recent research updates on Brenntag point to a more cautious stance on the stock, with several bearish analysts rethinking both ratings and price targets in light of concerns around chemical distribution and the company's growth profile.Analyseartikel • Dec 31
Is There An Opportunity With Brenntag SE's (ETR:BNR) 49% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Brenntag fair value estimate is €96.93 Current share price of...Narrative-Update • Dec 18
BNR: Weaker Chemical Demand Will Pressure Earnings And Drive Multiple Compression
Analysts have reduced their price target on Brenntag from about EUR 47 to EUR 42. This reflects expectations for a weaker growth profile and a deteriorating chemical market backdrop, even as margins hold up and valuation multiples compress slightly.Narrative-Update • Dec 04
BNR: Share Price Will Rebound As Cost Efficiencies Support Earnings Resilience
The analyst price target for Brenntag has been trimmed slightly from EUR 54.67 to about EUR 54.50, as analysts factor in a weaker chemical market backdrop, lower expected growth, and modestly softer profitability assumptions. Analyst Commentary Recent Street research reflects a more cautious stance on Brenntag, with several firms lowering price targets and reassessing the companys risk reward profile in light of a softer chemical demand outlook.Analyseartikel • Nov 29
Here's Why Brenntag (ETR:BNR) Can Manage Its Debt Responsibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Narrative-Update • Nov 20
BNR: Share Price Will Rebound As Chemical Market Challenges Ease
Brenntag's analyst fair value estimate has declined from €57.24 to €54.67, as analysts cite a weaker growth outlook and challenging chemical market conditions as reasons for the reduced price target. Analyst Commentary Recent analyst updates on Brenntag reflect a shift in sentiment as experts weigh the company’s outlook in the context of ongoing market challenges and valuation considerations.Analyseartikel • Nov 09
Brenntag SE's (ETR:BNR) Shares May Have Run Too Fast Too Soon
It's not a stretch to say that Brenntag SE's ( ETR:BNR ) price-to-earnings (or "P/E") ratio of 15.8x right now seems...Narrative-Update • Nov 05
BNR: Share Price Will Reflect Sector Headwinds as Market Conditions Stabilize
Brenntag's consensus analyst price target has been lowered noticeably in recent updates. Analysts cite a challenging chemical market environment and expectations for slower growth as key factors behind the revised outlook.Narrative-Update • Oct 22
Analyst Commentary Signals Lower Growth Expectations as Brenntag Faces Reduced Price Targets
Brenntag's analyst price target has been revised downward by approximately EUR 3 to EUR 57, as analysts point to ongoing reductions in expected growth and profitability in light of a challenging market backdrop. Analyst Commentary Recent analyst coverage of Brenntag reflects a cautious sentiment across the market, with lowered price targets and revised outlooks highlighting ongoing concerns about the company's growth prospects and market challenges.Narrative-Update • Oct 08
Specialty Chemicals And Biopharma Expansion Will Unlock Long-Term Value
Brenntag's analyst price target has been reduced by several euros, as analysts cite lower expectations for revenue growth, profit margins, and sector cyclicality. Analyst Commentary Recent street research updates reflect a mixed outlook on Brenntag, with several analysts adjusting their ratings and lowering price targets in light of the company’s ongoing performance and sector trends.Analyseartikel • Sep 20
Return Trends At Brenntag (ETR:BNR) Aren't Appealing
There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...Narrative-Update • Sep 05
Specialty Chemicals And Biopharma Expansion Will Unlock Long-Term Value
Analysts have maintained a cautious outlook on Brenntag due to its increased earnings cyclicality, macroeconomic uncertainties, and negative FX impacts, resulting in an unchanged consensus price target at €62.83. Analyst Commentary Bearish analysts cite increased cyclicality in Brenntag’s business versus specialty distributors, leading to greater earnings volatility.
Neues Narrative • Nov 25
Decisive Acquisitions And Digital Innovations Propel Transformation Amid Challenges
Strategic focus on divisional optimization and cost containment is set to enhance revenue and improve net margins by reducing expenses.Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2028 | 16,076 | 659 | 642 | 973 | 12 |
| 12/31/2027 | 15,574 | 598 | 641 | 963 | 13 |
| 12/31/2026 | 15,532 | 553 | 507 | 782 | 11 |
| 6/30/2026 | 15,156 | 365 | 513 | 803 | N/A |
| 3/31/2026 | 14,762 | 228 | 657 | 948 | N/A |
| 12/31/2025 | 15,172 | 265 | 674 | 967 | N/A |
| 9/30/2025 | 15,649 | 418 | 672 | 990 | N/A |
| 6/30/2025 | 16,000 | 423 | 587 | 908 | N/A |
| 3/31/2025 | 16,307 | 530 | 569 | 901 | N/A |
| 12/31/2024 | 16,237 | 536 | 564 | 907 | N/A |
| 9/30/2024 | 16,191 | 545 | 672 | 1,054 | N/A |
| 6/30/2024 | 16,210 | 603 | 821 | 1,188 | N/A |
| 3/31/2024 | 16,291 | 640 | 1,078 | 1,421 | N/A |
| 12/31/2023 | 16,815 | 715 | 1,343 | 1,664 | N/A |
| 9/30/2023 | 17,607 | 682 | 1,286 | 1,565 | N/A |
| 6/30/2023 | 18,619 | 753 | 1,279 | 1,551 | N/A |
| 3/31/2023 | 19,423 | 853 | 1,055 | 1,322 | N/A |
| 12/31/2022 | 19,429 | 887 | 690 | 957 | N/A |
| 9/30/2022 | 18,737 | 843 | 421 | 659 | N/A |
| 6/30/2022 | 17,374 | 754 | 221 | 442 | N/A |
| 3/31/2022 | 15,783 | 600 | 135 | 346 | N/A |
| 12/31/2021 | 14,383 | 448 | 189 | 389 | N/A |
| 9/30/2021 | 13,221 | 501 | 435 | 613 | N/A |
| 6/30/2021 | 12,364 | 461 | 684 | 864 | N/A |
| 3/31/2021 | 11,716 | 450 | 904 | 1,092 | N/A |
| 12/31/2020 | 11,795 | 467 | 1,020 | 1,219 | N/A |
| 9/30/2020 | 12,045 | 465 | 965 | 1,174 | N/A |
| 6/30/2020 | 12,419 | 475 | 786 | 1,009 | N/A |
| 3/31/2020 | 12,851 | 476 | N/A | 922 | N/A |
| 12/31/2019 | 12,822 | 467 | N/A | 879 | N/A |
| 9/30/2019 | 12,829 | 483 | N/A | 787 | N/A |
| 6/30/2019 | 12,796 | 467 | N/A | 621 | N/A |
| 3/31/2019 | 12,757 | 460 | N/A | 549 | N/A |
| 12/31/2018 | 12,550 | 461 | N/A | 375 | N/A |
| 9/30/2018 | 12,288 | 394 | N/A | 340 | N/A |
| 6/30/2018 | 11,959 | 383 | N/A | 341 | N/A |
| 3/31/2018 | 11,745 | 372 | N/A | 317 | N/A |
| 12/31/2017 | 11,743 | 361 | N/A | 405 | N/A |
| 9/30/2017 | 11,502 | 401 | N/A | 394 | N/A |
| 6/30/2017 | 11,229 | 394 | N/A | 450 | N/A |
| 3/31/2017 | 10,892 | 389 | N/A | 517 | N/A |
| 12/31/2016 | 10,498 | 360 | N/A | 540 | N/A |
| 9/30/2016 | 10,337 | 334 | N/A | 654 | N/A |
| 6/30/2016 | 10,325 | 335 | N/A | 641 | N/A |
| 3/31/2016 | 10,352 | 340 | N/A | 633 | N/A |
| 12/31/2015 | 10,346 | 365 | N/A | 594 | N/A |
| 9/30/2015 | 10,384 | 393 | N/A | 501 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: BNRDas prognostizierte Gewinnwachstum (15.1% pro Jahr) liegt über der Sparquote (2.1%).
Ertrag vs. Markt: BNRDie Erträge des Unternehmens (15.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt German (15.3% pro Jahr).
Hohe Wachstumserträge: BNRDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: BNRDie Einnahmen des Unternehmens (1.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt German (6.7% pro Jahr).
Hohe Wachstumseinnahmen: BNRDie Einnahmen des Unternehmens (1.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: BNRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.8%).
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/08/18 10:47 |
| Aktienkurs zum Tagesende | 2026/08/18 00:00 |
| Gewinne | 2026/06/30 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Brenntag SE wird von 29 Analysten beobachtet. 13 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Gaurav Jain | Barclays |
| James Stewart | Barclays |